Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crescita Therapeutics Inc (CTX.TO)

Crescita Therapeutics Inc (CTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Crescita Therapeutics Inc 2805, Place Louis-R-Renaud Laval QC H7V 0A3 CAN

https://www.crescitatherapeutics.com P: 450-680-4722

Sector:

Medical

Description:

Crescita Therapeutics Inc is a commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

Key Statistics

Overview:

Market Capitalization, $K 8,655
Shares Outstanding, K 18,614
Annual Sales, $ 19,580 K
Annual Net Income, $ -2,750 K
Last Quarter Sales, $ 5,393 K
Last Quarter Net Income, $ 753 K
60-Month Beta -0.06
% of Institutional Shareholders 0.87%

Growth:

1-Year Return -21.19%
3-Year Return -29.55%
5-Year Return -33.57%
5-Year Revenue Growth -2.60%

Per-Share Information:

Most Recent Earnings 0.04 on 11/05/25
Next Earnings Date N/A
Earnings Per Share ttm 0.02
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -114.29%
Dividend Payout Ratio 0.00%

CTX.TO Ratios

Ratio
Price/Earnings ttm 23.25
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 2.83%
Return-on-Assets % 2.07%
Profit Margin % -14.04%
Debt/Equity 0.02
Price/Sales 0.40
Price/Book 0.53
Book Value/Share 0.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar